Language
Country/Area
No result found
Do you know why L&R's products are so popular in the global medical community?
Lohmann & Rauscher (L&R) is a German-Austrian joint venture manufacturer of medical devices and sanitary products. The company was formed in 1998 by the merger of Germany's Lohmann and Austria's Rauscher, and is now headquartered in Lohmann & Rauscher International GmbH & Co. KG. The name is unified for operation. Headquartered in Rengsdorf, Germany and Vienna, Austria, L&R's clients include hospitals, doctors, nurses, pharmacies and consumer product retailers, making it one of the leading brands in the global healthcare industry.
"L&R's products are designed to improve medical efficiency and patient safety, which is one of the reasons why they are so popular."
Since Lohmann was founded in Frankfurt, Germany in 1851, L&R has gradually expanded its market influence in the field of medical products. Especially after the establishment of Rauscher in Austria in 1899, which focused on the production of surgical dressings and nursing supplies, the merger of the two companies became a natural thing. As time goes by, L&R's products are constantly innovating and upgrading, and recently it has continued to strengthen its production base to ensure product quality and supply chain stability.
The process of continuous innovation
L&R's history dates back to the early 20th century, particularly with the launch of Cellona Plaster Tape in 1930, a product that not only simplified plastering technology, but also led to a revolution. L&R's efforts in this regard enable healthcare workers to provide patients with the care and treatment they need more quickly and conveniently. In 1987, L&R introduced the widely recognized "Kitpacks" surgical kits, an innovation that greatly improved the standardization and efficiency of surgical preparation.
"Our goal is to put the health of our patients first and to continuously improve the quality and safety of medical care."
Global Expansion
As business continued to grow, L&R established multiple production sites around the world, including Austria, Germany, France, the Czech Republic and China. Such a layout not only ensures a stable supply of products, but also provides the ability to respond flexibly to the needs of different regions. In addition, L&R continues to conduct mergers and acquisitions to expand its technology and market scope, which is fully reflected in the acquisition of Solaris Inc. in 2014 and Varitex N.V. in 2016.
Facing challenges and coping with a changing market
Despite the many challenges posed by external factors such as the COVID-19 pandemic and the situation in Ukraine, L&R used these opportunities to launch high-demand products such as rapid testing equipment, further demonstrating its flexibility and innovation capabilities during the crisis. An L&R executive said that the increase in global health awareness has undoubtedly promoted the company's investment and focus in the medical products field.
"Our employees are not only the backbone of our company, but they are also the drivers of change in healthcare."
Social Responsibility and Sustainable Development
In addition to its commercial success, L&R's commitment to social responsibility and sustainable development has also won it wide acclaim. A wholly owned subsidiary was established in China in 2013 to enable it to better integrate into the Asian market. In addition, the wound management training program in Malaysia also demonstrates L&R's efforts to improve global medical standards.
Awards and recognition
L&R was awarded the Cardinal Comeback Award for its work during COVID-19 and has received several international awards for its involvement in global health initiatives. These achievements are undoubtedly the result of its excellent team and firm belief, and are also an important cornerstone for future development.
ConclusionL&R's success comes not only from its superior products and technologies, but also from its keen insight into market trends and its persistent pursuit of social responsibility. As the global medical industry is changing rapidly, how will L&R continue to maintain its leading position and play a key role in medical innovation?
